ArticleLeukemia2023

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.

Heinz Gisslinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.